The biological vaccine sector weakened, and Watson biology fell more than 6%

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

CRM Software Provider EC Nets more than 100 Mn in Series D2

Business services are quietly changing. In the past, traditional CRM vendors have never been able to solve the problems of high costs of home-grown PaaS, long delivery cycles, and uncontrollable projects in the face of personalised enterprise needs. The new model of combining SaaS+PaaS will enable SaaS vendors to break out of the customisation trap.

China's Largest Cloud-based HCM Solution Provider Beisen Passed HKEx Hearing

On 20 March 2023, Beisen Holdings Limited(Chinese：北森控股） passed the HKSE hearing with Morgan Stanley and CICC as joint sponsors.

CNMPA Approved World's First Inhaled COVID-19 Vaccine Mist

The liquid form of the vaccine is changed into an aerosol using a nebulizer. It can then be inhaled through the mouth using the nebulizer machine. According to CanSino, the vaccine can effectively induce comprehensive immune protection in response to SARS-CoV-2 after just one breath.

China Speed: Two COVID-19 Vaccines Recognized by WHO

As the second blow of the pandemic comes near the sight, China's newly-developed vaccines have been approved by the World Health Organization and available at an affordable price.